ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
Position in ELAN — Elanco Animal Health Inc
CIK 1164508
BOSTON, MA
Position in ELAN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$20,301,541
+$15,618,851 QoQ
Shares Held
848,372
+310.0% QoQ
Ownership
0.170%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 89.26367206838509.ToString("F0")%
Shared 0.ToString("F0")%
None 10.736327931614904.ToString("F0")%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $805,226,112 across 23 Drug Manufacturers - Specialty & Generic names. ELAN ranks #9 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,975,559 | $233,530,829 | |
| 2 | HLN |
Haleon plc
|
14,674,518 | $146,891,925 | |
| 3 | VTRS |
Viatris Inc
|
8,545,196 | $115,445,597 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
2,323,264 | $70,813,086 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
3,116,311 | $57,714,079 | |
| 6 | ANIP |
Ani Pharmaceuticals Inc
|
564,360 | $43,399,284 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
892,666 | $42,981,867 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
703,528 | $23,265,670 |
All Filings in ELAN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20,301,541 | 848,372 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $4,682,690 | 206,924 | Shares | Defined | 2026-02-13 | |
| 2025-06-30 | $4,432,269 | 310,383 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $154,686 | 14,732 | Shares | Defined | 2025-05-14 | |
| 2024-09-30 | $377,195 | 25,677 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $333,535 | 23,114 | Shares | Defined | 2024-08-14 | |
| 2023-03-31 | $1,557,608 | 165,703 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,347,873 | 601,299 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $4,233,398 | 341,128 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,066,531 | 207,159 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,053,804 | 78,720 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,225,590 | 43,185 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $207,446 | 5,980 | Shares | Defined | 2021-08-13 | |
| 2020-12-31 | $211,623 | 6,900 | Shares | Defined | 2021-02-12 | |
| 2020-06-30 | $1,507,935 | 70,300 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $26,046,846 | 1,163,325 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||